- Pharmaceutical companies
- Europe
- Sweden
- Incyte
Incyte in Sweden
E-mail: efromm@incyte.com
Address:
-
Incyte Biosciences Nordic AB
Barnhusgatan 3 111 23 Stockholm
Phone: +46 8 511 615 11
Fax: +46 (0)736 79 60 23
Other Incyte's locations around the world
Clinical Trials sponsored by Incyte
-
Incyte Biosciences Japan GKRekryteringDiffust stort B-cellslymfom | Non Hodgkins lymfomJapan
-
Incyte Biosciences International SàrlAvslutadAvancerade maligniteterFörenta staterna
-
Incyte Biosciences International SàrlAvslutadMetastaserande cancer | Avancerade maligniteterFörenta staterna
-
Incyte Biosciences International SàrlAvslutadLivmoderhalscancer | Hepatocellulärt karcinom | Matstrupscancer | Äggstockscancer | Mesoteliom | Icke-småcellig lungcancer (NSCLC) | Uroteliala karcinom | Merkel cellkarcinom | Diffust stort B-cellslymfom | Trippelnegativ bröstcancer | Njurcellscancer (RCC) | Småcellig lungcancer (SCLC) | Skivepitelcancer i huvud... och andra villkorFörenta staterna
-
Incyte Biosciences International SàrlIndragenBCR-ABL Positiv Akut Lymfoblastisk LeukemiTyskland, Frankrike, Tjeckien
-
Incyte Biosciences UKAvslutadAccelererad fas kronisk myelogen leukemi | Kronisk fas Kronisk myelogen leukemi | Philadelphia kromosompositiv akut lymfoblastisk leukemi | Blastisk fas kronisk myelogen leukemiStorbritannien, Irland
-
Incyte CorporationHar inte rekryterat ännu
-
Incyte CorporationRekryteringHidradenitis Suppurativa (HS)Förenta staterna, Österrike, Belgien, Kanada, Tyskland, Polen, Spanien, Australien, Danmark, Frankrike, Storbritannien, Japan, Bulgarien, Nederländerna, Tjeckien, Grekland, Italien
-
Incyte CorporationRekryteringIcke-segmentell vitiligoTyskland, Förenta staterna, Italien, Polen, Kanada, Frankrike, Bulgarien, Ungern, Storbritannien
-
Incyte CorporationRekryteringMyeloproliferativa neoplasmerSpanien, Japan, Frankrike, Italien, Tyskland, Australien, Storbritannien, Danmark, Kanada
About Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Europe and Japan. Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity. The commitment of our talented team of world-class scientists to continued scientific excellence has enabled us to identify new molecules, decipher new pathways and develop first-in-class and best-in-class medicines.